EKSO BIONICS HOLDINGS, INC. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ekso Bionics Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Ekso Bionics Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.64M, a 9.96% increase year-over-year.
  • Ekso Bionics Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$11.7M, a 27.5% increase year-over-year.
  • Ekso Bionics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$15.1M, a 2.85% increase from 2022.
  • Ekso Bionics Holdings, Inc. annual Operating Income (Loss) for 2022 was -$15.6M, a 12.5% decline from 2021.
  • Ekso Bionics Holdings, Inc. annual Operating Income (Loss) for 2021 was -$13.8M, a 4.04% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$15.1M +$444K +2.85% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-04
2022 -$15.6M -$1.73M -12.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-04
2021 -$13.8M -$537K -4.04% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$13.3M +$3.35M +20.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 -$16.6M +$10.4M +38.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 -$27M +$4.58M +14.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 -$31.6M -$4.03M -14.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-28
2016 -$27.6M -$6.03M -27.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-13
2015 -$21.6M -$4.77M -28.4% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 -$16.8M -$6.5M -63.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 -$10.3M +$3.95M +27.7% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 -$14.2M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.